EGFR and colorectal carcinoma: In the targeted therapy of CRC, although most drug targets (e.g. EGFR, VEGF, etc.)play an important role in the differentiation and metabolism of normal cells, drug administration claims that these drug targets cannot avoid their toxic effects on healthy tissues (2).